青春期卵巢上皮性交界瘤7例临床分析

的探讨青春期卵巢上皮性交界瘤的临床特点。方法回顾性分析本院2000年1月～2006年12月收治的7例20岁以下卵巢上皮性交界瘤患者的临床和病理特征。结果患者年龄16～19岁（平均17．8岁）。主要症状为腹胀5例（71．4％，其中3例伴腹痛）、腹痛4例（57．1％），盆腹腔包块，直径7～30cm（中位数20cm）；B超检查盆腹腔囊实性包块6例，实性包块1例，直径7～32cm（中位数19．9cm）。根据术中冰冻病理检查情况，均采用保留生育功能手术（6例患侧附件切除术，1例卵巢肿瘤剔除术）。手术病理分期Ia期卵巢粘液性交界瘤4例（57．1％），Ia期浆液性交界瘤2例（28．6％），Ⅲc期浆液性交界瘤1例（14．3％）。随访18～94月（平均53．9月），6例（85．7％）无复发，1例Ia期浆液性交界瘤患侧附件切除术后18月复发。结论青春期卵巢上皮性交界瘤Ia期多见，病理类型为浆液性和粘液性肿瘤，各期患者保守手术治疗效果均较好。     

30岁以下卵巢肿瘤患者223例临床分析

目的：探讨年龄30岁以下卵巢肿瘤患者的临床特点、病理类型、治疗及预后。方法：回顾性分析1992年10月-2007年10月间、年龄30岁以下223例卵巢肿瘤患者的临床资料。结果：有明显临床症状就诊者占71.30％（168／223）。良性肿瘤192例（86．10％）,恶性肿瘤包括低度恶性潜能上皮性肿瘤（LMP）31例（13．90％）。生殖细胞肿瘤91例、上皮性肿瘤72例、性索间质肿瘤9例、卵巢瘤样病变51例。良性肿瘤中蒂扭转者切除卵巢的比例高于非蒂扭转者。恶性肿瘤手术病理分期：Ⅰ期28例、Ⅱ期1例、Ⅲ期2例,其中22例保留生育功能。11例LMP患者术后未化疗,其余20例恶性肿瘤患者中19例进行化疗。随访时间10～181个月,27例无瘤生存,4例死亡;21例月经正常,9例有生育计划的患者中,7次妊娠,4次足月分娩。总5年生存率为80．21％,病理分期是影响生存率的主要因素。结论：30岁以下年轻患者卵巢肿瘤以良性、生殖细胞肿瘤为主。卵巢恶性肿瘤临床手术病理分期早期,手术应尽可能保留生育功能。化疗对卵巢及生育功能无明显影响。应重视年轻女性的临床表现并定期妇科检查。     

卵巢交界性上皮性肿瘤临床分析

目的分析卵巢交界性上皮性肿瘤的临床特点、治疗及预后情况,并探讨影响卵巢交界性肿瘤复发及预后的相关因素。方法回顾性分析1980年1月至2009年8月间在北京大学人民医院诊断的卵巢交界性上皮性肿瘤130例,所有患者均经手术治疗及术后病理证实。且经正规肿瘤术后随访12～240个月。结果平均发病年龄为42.3岁;Ⅰ、Ⅱ、Ⅲ期分别为106、6、18例;浆液性、黏液性和其他病理类型各48、63、19例;49.0%(51/104)的患者CA125升高;1%有微乳头浸润,0.05%有浸润性种植;所有患者均进行手术治疗,其中42.3%保留生育功能。复发率为6%(8例),其中18例行卵巢肿物剥除术2例复发,34例单侧或双侧附件切除术未见复发。肿瘤分期手术与一侧附件切除及单纯肿物剥除术的5年及10年存活率分别为100%、100%、95%。结论卵巢交界性肿瘤发病年龄较轻,Ⅰ期为主,黏液性肿瘤多见,预后良好,手术是主要的治疗手段,对早期患者行保留生育功能的手术是安全有效的,术后需长期随访。FIGO分期、微乳头型病变,浸润性种植及初次术后是否残留是影响复发及预后的相关因素。     

30岁以下卵巢肿瘤患者223例临床分析

目的:探讨年龄30岁以下卵巢肿瘤患者的临床特点、病理类型、治疗及预后.方法:回顾性分析1992年10月一2007年10月间、年龄30岁以下223例卵巢肿瘤患者的临床资料.结果:有明显临床症状就诊者占71.30%(168/223).良性肿瘤192例(86.10%),恶性肿瘤包括低度恶性潜能上皮性肿瘤(L,MP)31例(13.90%).生殖细胞肿瘤91例、上皮性肿瘤72例、性索间质肿瘤9例、卵巢瘤样病变5l例.良性肿瘤中蒂扭转者切除卵巢的比例高于非蒂扭转者.恶性肿瘤手术病理分期:I期28例、Ⅱ期l例、Ⅲ期2例,其中22例保留生育功能.11例LMP患者术后未化疗,其余20例恶性肿瘤患者中19例进行化疗.随访时间10～181个月,27例无瘤生存,4例死亡;21例月经正常,9例有生育计划的患者中.7次妊娠.4次足月分娩.总5年生存率为80.2l%,病理分期是影响生存率的主要因素.结论:30岁以下年轻患者卵巢肿瘤以良性、生殖细胞肿瘤为主.卵巢恶性肿瘤临床手术病理分期早期,手术应尽可能保留生育功能.化疗对卵巢及生育功能无明显影响.应重视年轻女性的临床表现并定期妇科检查.     

保留生育功能手术的卵巢交界性肿瘤61例临床研究

目的:探讨卵巢交界性肿瘤(BOT)的临床特征、保留生育功能的手术方案及预后。方法:回顾性分析四川省人民医院2005年1月至2019年12月收治的61例行保留生育功能手术的BOT患者的临床资料。结果:患者平均年龄27.66岁,67.21%的患者(41例)无明显临床症状;术前癌抗原125(CA_(125))升高者占74.14%(43/58),糖链抗原19-9(CA_(19-9))升高者占38.18%(21/56),人附睾蛋白4(HE4)升高者占8.70%(2/23)。国际妇产科联盟(FIGO)分期ⅠA期27例,ⅠB期8例,ⅠC期18例,ⅡB期2例,Ⅲ期6例。病理类型交界性浆液性卵巢肿瘤(S-BOT)32例,交界性黏液性卵巢肿瘤(M-BOT)27例,交界性浆黏液性卵巢肿瘤2例。M-BOT患者CA_(19-9)阳性率高于S-BOT者(60%vs 17.86%,P0.05)。随访58例,9例复发,复发率15.52%。单因素分析显示复发与FIGO分期、肿瘤累及卵巢范围、卵巢手术方式有关(P0.05),但多因素分析显示以上因素均不是肿瘤复发的独立危险因素。25例患者术后尝试妊娠,17例成功妊娠并足月分娩,1例正在妊娠;卵巢囊肿剥除组患者妊娠率高于单侧附件切除组(87.50%vs 64.71%),但差异无统计学意义(P0.05)。结论:BOT患者缺乏特异性临床症状及肿瘤标志物,诊断时多为早期,年轻有生育要求患者可行保留生育功能手术。手术方式首选附件切除术,早期BOT患者不推荐同时行分期手术。保留生育功能手术者术后复发风险可接受,复发后可再次行保留生育功能手术。     

卵巢交界性肿瘤有关问题

卵巢交界性肿瘤又称低度恶性潜能肿瘤,是介于良性肿瘤和恶性肿瘤之间的一组特殊类型的卵巢肿瘤。发病年龄轻,多数疾病为早期,预后较好,晚期及伴有浸润性种植者预后相对较差。主要病理类型为浆液性和黏液性交界性肿瘤。交界性肿瘤一般应行全面分期手术,年轻患者可行保留生育功能的手术。早期和低危病例无需术后辅助治疗,晚期和浸润性种植者可行术后辅助化疗。交界性肿瘤多远期复发,需长期随访。     

卵巢交界性肿瘤的临床处理

卵巢交界性肿瘤有比较令人满意的预后,但治疗常受两个因素的困扰;其一,该肿瘤多为术中偶然发现,其二,患者有生育要求。该肿瘤对化疗不敏感,因其细胞增殖不如恶性肿瘤快。卵巢交界性肿瘤常发生于生育年龄妇女,手术处理应强调恰当的手术病理分期并尽可能保留生育功能。     

卵巢交界性肿瘤的临床处理

卵巢交界性肿瘤有比较令人满意的预后,但治疗常受两个因素的困扰:其一,该肿瘤多为术中偶然发现,其二,患者有生育要求.该肿瘤对化疗不敏感,因其细胞增殖不如恶性肿瘤快.卵巢交界性肿瘤常发生于生育年龄妇女,手术处理应强调恰当的手术病理分期并尽可能保留生育功能.     

卵巢交界性肿瘤70例临床分析

目的分析卵巢交界性肿瘤患者的临床特点、治疗方案及预后,探讨影响卵巢交界性肿瘤患者的复发及预后因素。方法回顾性分析中国人民解放军第421医院2007年9月至2013年6月经术后病理证实的卵巢交界性肿瘤患者70例的临床资料及随访资料。结果70例卵巢交界性肿瘤患者平均年龄(39.19±17.58)岁;根据FIGO分期,Ⅰ期56例,Ⅱ期6例,Ⅲ期8例;病理类型浆液性35例,黏液性28例,其他7例;CA125升高33例,CA199升高19例;微乳头浸润7例,浸润性种植4例;所有患者均进行手术治疗,其中术后化疗23例,5例复发,肿瘤分期手术与单侧附件切除、单纯肿瘤剥除术5年生存率均为100%。结论卵巢交界性肿瘤发病年龄较轻,预后较好,手术为主要治疗方式,对早期患者可行保留生育功能的手术,但需进行长期随访观察。肿瘤病理分期,微乳头及浸润性种植可能是卵巢交界性肿瘤患者复发及预后的影响因素。     

卵巢交界性上皮性肿瘤50例诊断及治疗探讨

目的：探讨卵巢交界性上皮性肿瘤合理的治理方式和冰冻切片病理检查对卵巢交界性肿瘤的诊断价值。方法：对1980年至1999年我院收治的50例卵巢交界性上皮性肿瘤进行回顾性总结分析,行单侧附件切除术13例,子宫和双附件切除术加（或）不加大网膜,阑尾切除术37例,无一例行腹膜后淋巴结清扫,所有病例术后均无肉眼可见的残余瘤病灶,术后未进行化疗18例,其他32例术后进行了化疗,病例随访1－19年。结果：组织学类型浆液性28例,粘液性18例,分别占56％和36％,临床分期Ⅰ期49例（98％）,Ⅲ期1例（2％）。一侧为交界性肿瘤而对侧卵巢正常44例（88％）,40例（80％）在手术中做了冰冻切片病理检查,2例冰冻切片病理检查结果为良性,无一例将交界性肿瘤诊断为浸润性癌,其诊断符合率为95％（38／40）,随访期间所有病例均存活,结论：对Ⅰ期有生育要求的患者应尽量保留生育功能,对年轻患者应至少保留一侧卵巢,不必常规行淋巴结清扫,不必化疗,冰冻切片病理检查对术中诊断有较大的参考价值。     

Laparoscopic treatment of ovarian tumors in children: an experience of seven cases in Mansoura University Hospital

All ovarian tumors in children are rare. Laparoscopic ovary-sparing treatment of ovarian tumor would be the preferred surgical approach for children in order to preserve future fertility. The objective of this research is to study the experience of gynecology department in Mansoura University Hospital in laparoscopic treatment of ovarian tumors in children. This study included seven patients with age range of 7 to 11 years presented with ovarian tumors. The following items were fulfilled for all studied cases: age at diagnosis, presenting complaints, blood samples for detection of tumor markers, abdominal ultrasonography, abdominal magnetic resonance imaging (MRI), treatment by laparoscopy, histopathological examination, and the outcome of the patients. All ovarian tumors were benign. Three cases were found to be cystic teratomas, two cases were benign serous cystadenoma, only one case was cystadeno-fibroma and one case was solid tumor, and its histology did not give a clear diagnosis, but no malignant cells were found. Unilateral salpingo-oophorectomy was carried out in three patients, whereas the other four patients had unilateral ovarian cystectomy. In one case, intraoperative spillage during excision of the tumoroccurred. Recovery of all patients was good and without any complications. Laparoscopic conservative surgery as a treatment for benign ovarian tumor in childhood gives a good chance to preserve future fertility.     

CyclinD1、C-erbB2及bcl-2基因在卵巢上皮性肿瘤中的表达及其临床意义

目的 :检测癌基因CyclinD1、C erbB2及bcl 2在卵巢上皮肿瘤中的表达 ,探讨它们在卵巢肿瘤发生、发展中的作用及临床、病理意义。方法 :应用免疫组化SP法检测72例恶性卵巢肿瘤、12例交界性卵巢肿瘤、2 1例良性肿瘤及 10例正常卵巢组织中Cy clinD1、C erbB2及bcl 2基因的表达情况。结果 :1.卵巢恶性、交界性及良性肿瘤中Cy clinD1阳性率依次为 2 7.78%、33.3%、9.5 2 %。恶性及交界性肿瘤阳性率明显高于良性肿瘤 ,其阳性率与组织学分级呈负相关 ,而与患者年龄、临床分期、组织学类型无关 ;2 .卵巢恶性、交界性及良性肿瘤中C erbB2的阳性率依次为 5 6 .9%、4 1.6 7%、14.2 8%。恶性及交界性肿瘤阳性率明显高于良性肿瘤 ,差异有显著性。C erbB2阳性表达在组织分化差及期别晚的肿瘤中较分化好、期别早者高 ;3.卵巢恶性、交界性、良性肿瘤中bcl 2的阳性表达率依次为 6 3.89%、5 0 %、2 8.5 %。恶性及交界性肿瘤与良性肿瘤之间的表达差异有显著性。组织分化差、期别早的肿瘤中bcl 2的阳性率较分化好、期别晚者高 ;4 .两种及两种以上基因同时表达率 (5 1.4 % )显著高于单基因表达 (2 7.79% )。CyclinD1与C erbB2基因表达呈负相关。结论 :CyclinD1、C erbB2及bcl 2基因在卵巢癌发生、发展中起重要作用 ,表明细胞?     

Teratomas of the ovary: a clinico-pathological evaluation of 87 patients from one institution during a 10-year period

AIM: To present the classification and diagnostic problems encountered between teratomas and other ovarian tumors as well as with other benign entities diagnosed and treated in our institution. METHODS: We analysed retrospectively the clinical and pathological characteristics of 87 teratomas examined in our hospital during the last ten years. RESULTS: Teratomas constituted 5% of all ovarian tumors. The age range was from 11-69 years old (median: 35). The most frequent symptom was lower abdominal pain in 68% of patients. A pelvic mass was noted in 3% of cases. A pregnancy was present in 3% of patients. In ten cases the tumors were bilateral. Tumor size ranged from 1-16 cm in diameter (median: 7.17 cm). The treatment consisted of cystectomy in 66% of the cases, oophorectomy in 23% or hysterectomy with both adnexa in 11% of cases. Fifty-seven cases presented with a histological diagnosis of mature teratoma, biphasic or triphasic type, three cases with monodermal teratoma, ten cases with ovarian neoplasms of mixed type, 15 cases with epidermal cysts, and two cases with benign cysts. Malignant changes within the teratomas were seen in 5% cases. CONCLUSION: Teratomas are common ovarian tumors at any age, especially during the reproductive age, with a low rate of complications and malignant transformation. The treatment should be based on patient age, fertility status, tumor size, the cystic or solid nature of the tumor and bilaterality.     

Benign or malignant ovarian neoplasms and ovarian endometriomas

STUDY OBJECTIVE: To investigate clinical features and biologic behavior of ovarian cancer that might be closely related to endometrioma and/or endometriosis. DESIGN: Retrospective study (Canadian Task Force classification II-2). SETTING: University hospital. PATIENTS: All 324 women who were operated for endometriomas and/or ovarian tumors 5 cm or greater in diameter between January 1988 and December 1997. INTERVENTION: One hundred twelve women underwent laparoscopic surgery and 212 had laparotomy. MEASUREMENTS AND MAIN RESULTS: All tissues were evaluated histologically. Clinical examinations including ultrasound and serum tumor makers were performed in all patients preoperatively. No malignancies were found at laparoscopic surgery (76 endometriomas, 36 ovarian tumors). The frequency of endometriosis in benign, borderline malignant, and malignant tumors was 9.7%, 12.5%, and 11.4%, respectively. Endometriosis was present most frequently (40%) in women with endometrioid adenocarcinoma. It was present in 81 patients with endometriomas and 25 with ovarian neoplasms. Of these, nine women (8.5%) had malignant tumors, including borderline malignancy. Among patients with malignant tumors, those without endometriosis were significantly older (mean +/- SD age 54.9 +/- 16.2 yrs) than those with endometriosis elsewhere in the pelvis (45.9 +/- 8.9 yrs). CONCLUSION: Endometriosis may be closely related to ovarian tumors such as endometrioid adenocarcinoma. Surgeons should be aware of this possibility, and candidates for laparoscopic surgery should be carefully selected based on preoperative evaluations.     

Are borderline tumors of the ovary safely treated by laparoscopy?

OBJECTIVES: To evaluate the risk of the laparoscopic approach to patients with borderline ovarian tumors compared to the laparotomic management. METHODS: We treated or followed in our institution 479 women with borderline ovarian tumor. Sixty-two patients had fertility-sparing surgery followed by restaging or follow-up intervention: 30 operated by laparoscopy, 32 by laparotomy. Restaging surgery was performed in five cases and second-look surgery in 57. RESULTS: The diameter of the cyst is significantly lower in patients treated by laparoscopy, especially in women who underwent cystectomy (4.7 cm) compared to oophorectomy (10 cm, P = 0.008). Rupture of the cyst and stage IC were more frequent in the laparoscopic group. After a median follow-up of 61 months for the laparoscopic group and 77 months for the laparotomic group, we observed 11 patients (37%) with persistent disease after primary laparoscopy (adnexa, five cases; peritoneal implants, three cases; both patterns, three cases). After primary laparotomy, no patients showed early persistence of tumor, and ovarian relapses were diagnosed in seven women (22%) 33-138 months after laparotomy. The univariate analysis for the risk of neoplastic persistence after primary laparoscopy shows that patients with cysts greater than 5 cm have a higher risk (odds ratio 9.7, P = 0.02) compared to smaller cysts. No other factors proved significant, but the odds ratios for patients with serous tumor (5.8), stage IC (2.0), and those undergoing cystectomy (1.9) suggest a relationship to the probability of persistence. CONCLUSION: Laparoscopic treatment in borderline ovarian tumors should be reserved to masses not greater than 5 cm. When conservative therapy is desired, the entire affected ovary should be removed. If the neoplasia is bilateral, cystectomy could be allowed in women who wish to preserve fertility, although they are at high risk of relapse.     

286例妊娠合并卵巢肿瘤的临床分析

目的:探讨妊娠合并卵巢肿瘤的临床病程特点,以及相应的诊断和处理对母儿结局的影响。方法:回顾分析2003年3月至2010年12月在上海市第一妇婴保健院住院分娩的286例妊娠合并卵巢肿瘤患者的临床资料,分析比较诊断时孕周,妊娠期间卵巢肿瘤的特点、对妊娠结局影响、分娩方式,病理特点等,并对上述因素进行相关分析。结果:妊娠合并卵巢肿瘤的孕妇阴道分娩54例,剖宫产232例,剖宫产率81.12%;剖宫产获得的232例病理结果中,良性肿瘤227例,交界性肿瘤5例。良性肿瘤行卵巢肿瘤剥除术或患侧附件切除术,交界性肿瘤行患侧附件切除术或肿瘤减灭术;妊娠合并卵巢交界性肿瘤组新生儿体重及分娩孕周均明显低于妊娠合并卵巢良性肿瘤组(P<0.05)。结论:妊娠合并卵巢肿瘤以良性肿瘤最常见。因早期妊娠时缺乏典型的临床症状而不易早期诊断,故应加强孕前及早孕期间的检查;妊娠早期应行B超检查提高卵巢肿瘤检出率;剖宫产术中应仔细探查双侧附件,及时发现卵巢肿瘤;妊娠合并交界性肿瘤,由于终止妊娠时期早,故围产期母儿并发症较高,其处理原则需根据患者年龄、生育情况、组织类型、肿瘤期别、妊娠期限、胎儿成熟度评价等而异。     

Borderline ovarian tumors in reproductive-age women. Fertility-sparing surgery and outcome

OBJECTIVE: To evaluate the fertility and survival outcomes in young women with borderline ovarian tumors treated with fertility-sparing surgery. STUDY DESIGN: From 1985 to 2002, 25 women with borderline ovarian cancers surgically managed with preservation of the uterus and at least a portion of 1 ovary were identified from tumor registry databases at 2 southern California hospitals. Data for analysis were collected from hospital charts, office records and tumor registry files. RESULTS: Twenty-five patients (median age, 29 years) with borderline ovarian tumors, including 10 with stage IA, 3 with stage IC, 1 with stage IIIA and 11 with unstaged disease, underwent fertility-sparing surgery, consisting of unilateral adnexectomy in 19, unilateral adnexectomy with contralateral cystectomy in 5 and unilateral cystectomy in 1. No disease recurred, providing an overall survival of 100%. Fertility status was available on 15 patients 4-157 months after surgery; 6 of them attempted to become pregnant. Five women had successful pregnancies, with a total of 5 live births. One woman underwent assisted reproductive techniques, became pregnant but aborted. The median follow-up was 80 months (range, 4-157). CONCLUSION: Conservative surgery for borderline ovarian tumors should be considered for women in the reproductive age group who desire preservation of fertility.     

青少年卵巢肿瘤的临床病理分析

目的:探讨青少年卵巢肿瘤的临床病理特点。方法:回顾性分析67例20岁以下的青少年卵巢肿瘤患者的临床表现、诊断、病理和治疗。结果:临床症状以腹痛、腹部包块为主,肿瘤扭转率高。良性肿瘤41例,交界性3例,恶性23例;组织学类型以生殖细胞肿瘤最多。恶性肿瘤中65.2%为FIGOI期。除8例恶性患者进行了肿瘤细胞减灭术外,其余59例均进行了保留生育功能的手术。15例恶性肿瘤患者术后化疗。单因素分析显示仅化疗方案影响生存期,BEP优于VAC。结论:青少年卵巢肿瘤的临床病理特点与成人不同,首选保留生育功能的手术,BEP是恶性患者的一线化疗方案。     

MMP-9及TIMP-1在卵巢上皮性肿瘤中的表达

目的 :探讨MMP 9和TIMP 1在卵巢上皮性肿瘤中的表达。方法 :采用免疫组化方法检测 12 5例卵巢上皮性肿瘤及 7例正常卵巢组织中MMP 9和TIMP 1的表达。结果 :MMP 9在交界性 (5 .4 0± 2 .2 8)和恶性卵巢上皮性肿瘤 (6.88± 2 .0 9)中的表达显著高于良性卵巢上皮性肿瘤 (3.80± 1.5 6)和正常卵巢组织 (2 .69± 1.19) (P <0 .0 1) ;TIMP 1在正常卵巢组织、良性、交界性和恶性卵巢上皮性肿瘤中的表达分别为 1.86± 1.10、3.89± 1.11、3.97± 0 .98和 4 .99± 1.70 ,差异有显著性 (P <0 .0 1)。结论 :MMP 9可能参与卵巢上皮性肿瘤的发生和侵袭 ,TIMP 1在卵巢肿瘤的演化过程中除可抑制肿瘤的侵袭和转移外 ,可能还有非MMP 9抑制活性的作用     

腹腔镜在附件包块治疗中的价值和安全性(附2083例报道)

目的:评价腹腔镜在附件包块治疗中的价值及安全性。方法:回顾分析2000年1月至2003年12月北京协和医院术前诊断为良性附件包块2083例的腹腔镜手术治疗情况。患者平均33.4±8.9岁,绝经后妇女占1.8%。术中怀疑卵巢恶性肿瘤者送冰冻病理检查。计算腹腔镜术中诊断卵巢恶性肿瘤的敏感性(SEN)、特异性(SPE)、阳性预测值(PPV)及阴性预测值(NPV)。结果:2 083例患者中,2 067例为良性肿瘤,16例(0.77%)患者为卵巢交界性肿瘤(LMP)或卵巢癌,其中14例LMP及卵巢癌在术中确诊,2例卵巢癌术后确诊。55例(2.6%)患者术中可疑恶性送冰冻病理检查,检查结果为良性肿瘤41例(74.5%),LMP 8例(14.5%),卵巢癌6例(10.9%)。术后病理结果:良性肿瘤41例(74.5%),LMP 7例(12.7%),卵巢癌7例(12.7%)。术中冰冻与术后病理的符合率为98.2%。腹腔镜诊断卵巢恶性肿瘤的SEN为87.5%、SPE为98%、PPV为25.5%、NPV为99.9%。卵巢良性肿瘤2 067例,均进行了卵巢囊肿剔除术、附件切除术等。无中转开腹或围手术期并发症。16例LMP或卵巢癌患者中,7例行腹腔镜手术包括3例腹腔镜分期手术。16例患者术后平均随诊17.3月。1例LMP一侧附件切除术后4年对侧卵巢出现交界性肿瘤,行腹腔镜囊肿剔除术,其余病例均无复发征象。结论:腹腔镜可作为术前诊断为良性的附件包块的首选手术方式,术中意外发现卵巢LMP或者恶性肿瘤的机会较低。对可疑恶性的卵巢肿瘤,术中应进行冰冻病理检查。